ESR1 and breast cancer: It was shown in this matched cohort study that the performance of procedures in women with breast cancer for which hormonal stimulation was required was not associated with a higher rate of breast cancer relapse, regardless of tumor size, the number of involved lymph nodes, estrogen receptor status, and chemotherapy treatment (pre- or postoperatively).